Archive - February 2019
Merck & Co to buy IO specialists Immune Design for $300m
Greater Manchester backs move to outcome-based payment
More good news, and some bad, for Merck’s Keytruda
NHS implements new AI code of conduct
Xencor’s Novartis-partnered bispecific on hold after patient deaths
Young people in UK ‘suffering from long-term conditions’ despite healthier life choices
Cell therapy trial shows ‘significant’ vision restoration
European Medicines Agency forced to pay London lease